Gapping up
In reaction to strong earnings/guidance: PFPT +12.2%, AMD +9.6%, EGHT+4.5%, VOD +3.8%, CLS +3.2%, SAM +2.9%,CRH +2.4%, ETFC +2.3%, STI +1.9%, SLB +0.5%, V +0.5% (also PayPal and Visa announce a U.S. strategic partnership; adds $5 bln to buyback)
In reaction to strong earnings/guidance: PFPT +12.2%, AMD +9.6%, EGHT+4.5%, VOD +3.8%, CLS +3.2%, SAM +2.9%,CRH +2.4%, ETFC +2.3%, STI +1.9%, SLB +0.5%, V +0.5% (also PayPal and Visa announce a U.S. strategic partnership; adds $5 bln to buyback)
Select drybulk stocks trading higher: EGLE +17.2%, DRYS +15.5%
Other news:
Other news:
- CADC +23.1% (thin name with above average volume yesterday)
- KONE +18.2% (low float momentum name yesterday, no news)
- PBYI +17.8% (reported positive data from Phase III clinical trial of PB272 (neratinib) for the extended adjuvant treatment of HER2-positive early stage breast cancer)
- EYES +14.3% (announces 'positive' five-year outcomes associated with patients using the Argus II Retinal Prosthesis System)
- SPU +7.6% (continued momentum)
- DXCM +4.1% (FDA voted in favor of the proposed non-adjunctive indication for the DexCom G5 Mobile CGM system)
- CVRR +3.4% (still checking)
- AMID +3.1% (will maintain quarterly distribution of $0.4125 per common unit)
- CNC +2.1% (Centene awarded Defense Health Agency contract; total potential contract value, including all option periods, is estimated at $17.72 bln)
- BMRN +1% (announces interim results of open-label, Phase 1/2 study of BMN 270, will be presented; Betaville update discusses Roche speculation)